728
S U B J E C T I N D E X
Adipose tissue (see also Fat),
brown, 595-7
glycogen and, 595-7
insulin and, 595, 597
of m a m m a r y gland, 634-5
organ culture of, 73, 128, 265
Adrenal gland,
A C T H on cortex of, 603
ascorbic acid in, 685
confronted with pituitary, 604
culture o f whole, 71
and lymphocytes, 608
production o f steroids in, 604
steroids of, and m a m m a r y gland, 633-4
Adrenaline,
on neurofibril formation, 616
on nuclear structure, 616
Adrenochrome,
and mitochondria, 218
and mitosis, 218
Adrenocorticotrophin, see A C T H
Aerobic pathways, 251, 2 5 4 - 8
Agar,
- extract o f egg, 572
for organ cultures, 73, 75-6, 78, 5 5 3 - 5 ,
561, 568-9
and radiation o f cultures, 78
in slide chambers, 39-41
as source o f nutrients, 300
as substratum for cells, 152
A g e ,
and ability to aggregate, 502, 522
and action o f oestrone, 6 2 8 - 9
of bone, and parathyroid, 647
of bone, and thyroxine, 6 4 1 - 2
o f cells in cell cycle, 323, 334-5
and cellular activity, 30, 146, 502
and ionic requirements, 108
and latent period, 192
of mammary gland, and hormones,
638
mucopolysaccharides and, 354
o f muscle and ascorbic acid content,
687
and pattern o f reaggregation, 498,
5 0 3 - 4
and properties o f embryo extract, 470
of skin, and vitamin A , 664-7
Agglutination,
as distinct from aggregation, 519-20
Aggregation (reaggregation, o f cells),
and agglutination, 519-20
and age o f donor, 498, 5 0 3 - 4
autoradiography and, 508-10
o f blastomeres, 490
of cartilage, 174, 507-8, 511-12, 515,
518, 522
cell division in, 519
b y centrifugation, 4 9 4 - 5
and chimaeras, 508-9, 511-12
cinematography and, 492, 508
conditions affecting, 490, 493, 495-505
dedifferentiation in, 508, 515
and differentiation, 69, 4 7 2 - 3 , 506,
508-10, 515, 522-3
in different sizes, 492, 496, 498, 501-6,
522
from dissociated cells, 51, 173-4, 195,
490
of epithelial cells, 505
of fibroblasts, 505
and fusion, 502
gradients in, 523
histogenesis in, 494, 505-6, 508-10,
519
induction in, 509-10
inhibition of, 500-1, 521
interspecific, 174, 511-12, 517-18
isotypic and heterotypic, 507, 516-18
mediated, 491, 4 9 4 - 8 , 5 0 8 - 1 0 , 5 1 1 , 5 1 6
and metabolism, 499
and monolayers, 63, 504, 515
in normal development, 490
patterns of, 4 9 6 - 8 , 508-10, 519
primary, secondary and tertiary, 519
protein and, 500
protein synthesis and, 521
b y rotation, 495, 498-501
self-, 491-4, 511, 516
specificity in, 501
temperature and, 69, 496, 498-500,
510
and virus-binding capacity, 505
and vitamin A , 664
Alanine,
accumulation in medium, 304
and differentiation, 568-9
from glucose, 250, 283, 299
and heart tissue, 299, 303
and kidney tissue, 303
and L-cells, 114, 2 8 7 - 9
and liver, 303
precursors of, 2 8 7 - 9
rate o f formation of, 295
S U B J E C T I N D E X
Adipose tissue (see also Fat),
brown, 595-7
glycogen and, 595-7
insulin and, 595, 597
of m a m m a r y gland, 634-5
organ culture of, 73, 128, 265
Adrenal gland,
A C T H on cortex of, 603
ascorbic acid in, 685
confronted with pituitary, 604
culture o f whole, 71
and lymphocytes, 608
production o f steroids in, 604
steroids of, and m a m m a r y gland, 633-4
Adrenaline,
on neurofibril formation, 616
on nuclear structure, 616
Adrenochrome,
and mitochondria, 218
and mitosis, 218
Adrenocorticotrophin, see A C T H
Aerobic pathways, 251, 2 5 4 - 8
Agar,
- extract o f egg, 572
for organ cultures, 73, 75-6, 78, 5 5 3 - 5 ,
561, 568-9
and radiation o f cultures, 78
in slide chambers, 39-41
as source o f nutrients, 300
as substratum for cells, 152
A g e ,
and ability to aggregate, 502, 522
and action o f oestrone, 6 2 8 - 9
of bone, and parathyroid, 647
of bone, and thyroxine, 6 4 1 - 2
o f cells in cell cycle, 323, 334-5
and cellular activity, 30, 146, 502
and ionic requirements, 108
and latent period, 192
of mammary gland, and hormones,
638
mucopolysaccharides and, 354
o f muscle and ascorbic acid content,
687
and pattern o f reaggregation, 498,
5 0 3 - 4
and properties o f embryo extract, 470
of skin, and vitamin A , 664-7
Agglutination,
as distinct from aggregation, 519-20
Aggregation (reaggregation, o f cells),
and agglutination, 519-20
and age o f donor, 498, 5 0 3 - 4
autoradiography and, 508-10
o f blastomeres, 490
of cartilage, 174, 507-8, 511-12, 515,
518, 522
cell division in, 519
b y centrifugation, 4 9 4 - 5
and chimaeras, 508-9, 511-12
cinematography and, 492, 508
conditions affecting, 490, 493, 495-505
dedifferentiation in, 508, 515
and differentiation, 69, 4 7 2 - 3 , 506,
508-10, 515, 522-3
in different sizes, 492, 496, 498, 501-6,
522
from dissociated cells, 51, 173-4, 195,
490
of epithelial cells, 505
of fibroblasts, 505
and fusion, 502
gradients in, 523
histogenesis in, 494, 505-6, 508-10,
519
induction in, 509-10
inhibition of, 500-1, 521
interspecific, 174, 511-12, 517-18
isotypic and heterotypic, 507, 516-18
mediated, 491, 4 9 4 - 8 , 5 0 8 - 1 0 , 5 1 1 , 5 1 6
and metabolism, 499
and monolayers, 63, 504, 515
in normal development, 490
patterns of, 4 9 6 - 8 , 508-10, 519
primary, secondary and tertiary, 519
protein and, 500
protein synthesis and, 521
b y rotation, 495, 498-501
self-, 491-4, 511, 516
specificity in, 501
temperature and, 69, 496, 498-500,
510
and virus-binding capacity, 505
and vitamin A , 664
Alanine,
accumulation in medium, 304
and differentiation, 568-9
from glucose, 250, 283, 299
and heart tissue, 299, 303
and kidney tissue, 303
and L-cells, 114, 2 8 7 - 9
and liver, 303
precursors of, 2 8 7 - 9
rate o f formation of, 295